ISSN 2147-9720 | E-ISSN 2148-4279
Case based Review
Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab
1 Department of Rheumatology, Hospital del Mar, Barcelona, Spain  
Eur J Rheumatol 2019; 6: 150-152
DOI: 10.5152/eurjrheum.2019.17169
Key Words: Systemic lupus erythematosus, belimumab, biological treatments, serositis, pleuropericarditis
Abstract

 

Systemic lupus erythematosus (SLE) is characterized by a wide variety of manifestations and a difficult disease control in some patients. We present the case of a 51-year-old woman who presented with a flare of SLE including arthritis and pleuropericarditis that responded to neither leflunomide, methotrexate, nor high doses of prednisone. After initiating treatment with belimumab, the patient experienced a quick and notorious improvement. She remains stable to this day while continuing belimumab therapy.

 

 

Cite this article as: Carrión-Barberà I, Salman-Monte TC, Castell S, Castro-Domínguez F, Ojeda F, Monfort J. Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab. Eur J Rheumatol 2019; 6(3): 150-2.

Key Words
Authors
All
Author’s Corner
Survey
AVES | Copyright © 2019 Medical Research and Education Association | Latest Update: 24.07.2019